Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04331288 · ClinicalTrials.gov registry record · Phase 1

Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)

A Phase 1 study, sponsored by Pop Test Oncology.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target

NCT04331288: Completed Phase 1 study, sponsored by Pop Test Oncology.

NCT04331288 is a Phase 1 study that has completed, run by Pop Test Oncology. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04331288, a Phase 1 study, has completed, sponsored by Pop Test Oncology.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this clinical study is to assess pharmacokinetic interactions between ethanol (EtOH) and PT150 (900 mg qd) in non-treatment-seeking alcohol-experienced volunteers-(to include military service members, veterans and/or civilians).

Primary Outcome

Estimates of maximum concentration (Cmax) of PT150 will be calculated and compared from PT150 steady state alone (days 6-7) to concurrent steady state of PT150 with ethanol exposure (days 7-9).

Interventions

  • DRUG PT150
  • OTHER Beverage

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-11-01
Est. Completion 2023-10-27
Phase Phase 1
Pop Test Oncology

3 total trials

What the finished NCT04331288 record still lists

NCT04331288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which PT150 is the first listed.

NCT04331288 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04331288 about?

NCT04331288 is a clinical study titled "Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)". The purpose of this clinical study is to assess pharmacokinetic interactions between ethanol (EtOH) and PT150 (900 mg qd) in non-treatment-seeking alcohol-experienced volunteers-(to include military service members, veterans and/or civilians).

What is the current status of trial NCT04331288?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2021-11-01. Estimated completion is 2023-10-27.

What interventions are being tested in trial NCT04331288?

The interventions under investigation include: PT150 (DRUG), Beverage (OTHER).

Who is sponsoring clinical trial NCT04331288?

This trial is sponsored by Pop Test Oncology, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04331288's enrollment target sits among peer trials

10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04331288, the US trial registry maintained by the National Library of Medicine. NCT04331288 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.